Innovations in Artificial Intelligence and Genomics Research

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology TOE depicts life sciences trends across genomics. Discovery of genetic risk factors for common complex diseases, an artificial intelligence platform for assembling biological data, advancing precision oncology via whole genome sequencing, and cutting edge adjacent technologies have been profiled. Ongoing clinical trials for whole genome sequencing have also been presented.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology appl

Table of Contents

Innovations in Artificial Intelligence and Genomics ResearchAdvances in Deep Learning and Precision GenomicsDiscovering Genetic Risk Factors for Common Complex DiseasesAssembling Biological Data to Artificial Intelligence PlatformAdvancing Precision Oncology via Whole Genome SequencingInnovating by Introducing Cutting Edge Adjacent Technologies Clinical Trials and Industry InteractionsOngoing Clinical TrialsIndustry Interactions




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.